Confo Therapeutics appoints Dieter Weinand to its Board of Directors as Independent Chairman

– BELGIUM, Brussels –  Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors, today announced the appointment of Dieter Weinand to its Board as Independent Chairman, bringing more than 35 years of experience in the pharmaceutical industry and over 25 years as the leader of geographic and strategic business units and drug commercialization efforts across global organizations.…

Celyad Oncology appoints Dr. Georges Rawadi as CEO

– BELGIUM, Mont-St-Guibert – Celyad Oncology (EBR: CYAD | Nasdaq: CYAD), a biotechnology company focused on innovative technologies for chimeric antigen receptor (CAR) T-cell therapies, today announced the appointment of Dr.